{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:49:45Z","timestamp":1791359385491,"version":"4.3.1"},"publisher-location":"Berlin, Heidelberg","reference-count":80,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/82_2026_360","type":"book-chapter","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:53:19Z","timestamp":1791355999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["15-Hydroxyprostaglandin Dehydrogenase: A Key Metabolic Enzyme for Prostaglandins, 12-Hydroxyheptadecatrienoic Acid, and Resolvins"],"prefix":"10.1007","author":[{"given":"Hsin-Hsiung","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-6694","authenticated-orcid":false,"given":"Haining","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1963-1585","authenticated-orcid":false,"given":"Nan","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"8","key":"360_CR1","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/wnl.58.8.1277","volume":"58","author":"G Almer","year":"2002","unstructured":"Almer G, Teismann P, Stevic Z, Halaschek-Wiener J, Deecke L, Kostic V, Przedborski S (2002) Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology 58(8):1277\u20131279. https:\/\/doi.org\/10.1212\/wnl.58.8.1277","journal-title":"Neurology"},{"issue":"9","key":"360_CR2","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/bi00885a025","volume":"4","author":"E \u00c4ngg\u00e5rd","year":"1965","unstructured":"\u00c4ngg\u00e5rd E, Samuelsson B (1965) Prostaglandins and related factors. XLII. Metabolism of prostaglandin E 3 in Guinea pig lung *. Biochemistry 4(9):1864\u20131871. https:\/\/doi.org\/10.1021\/bi00885a025","journal-title":"Biochemistry"},{"issue":"3","key":"360_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1748-1716.1971.tb04914.x","volume":"81","author":"E \u00c4ngg\u00e5rd","year":"1971","unstructured":"\u00c4ngg\u00e5rd E, Larsson C, Samuelsson B (1971) The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin-\u0394 13\u2212 reductase in tissues of the swine. Acta Physiol Scand 81(3):396\u2013404. https:\/\/doi.org\/10.1111\/j.1748-1716.1971.tb04914.x","journal-title":"Acta Physiol Scand"},{"issue":"32","key":"360_CR4","doi-asserted-by":"publisher","first-page":"22847","DOI":"10.1074\/jbc.M603766200","volume":"281","author":"M Arita","year":"2006","unstructured":"Arita M, Oh SF, Chonan T, Hong S, Elangovan S, Sun Y-P, Uddin J, Petasis NA, Serhan CN (2006) Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J Biol Chem 281(32):22847\u201322854. https:\/\/doi.org\/10.1074\/jbc.M603766200","journal-title":"J Biol Chem"},{"issue":"8","key":"360_CR5","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1007\/s12035-018-0889-z","volume":"55","author":"E Bisicchia","year":"2018","unstructured":"Bisicchia E, Sasso V, Catanzaro G, Leuti A, Besharat ZM, Chiacchiarini M, Molinari M, Ferretti E, Viscomi MT, Chiurchi\u00f9 V (2018) Resolvin D1 halts remote neuroinflammation and improves functional recovery after focal brain damage via ALX\/FPR2 receptor-regulated microRNAs. Mol Neurobiol 55(8):6894\u20136905. https:\/\/doi.org\/10.1007\/s12035-018-0889-z","journal-title":"Mol Neurobiol"},{"issue":"3","key":"360_CR6","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/0006-291X(81)91834-9","volume":"101","author":"DG-B Chang","year":"1981","unstructured":"Chang DG-B, Tai H-H (1981) Prostaglandin 9-ketoreductase\/type II 15-hydroxyprostaglandin dehydrogenase is not a prostaglandin specific enzyme. Biochem Biophys Res Commun 101(3):898\u2013904. https:\/\/doi.org\/10.1016\/0006-291X(81)91834-9","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"360_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/0006-291X(81)91806-4","volume":"99","author":"DG-B Chang","year":"1981","unstructured":"Chang DG-B, Sun M, Tai H-H (1981) Prostaglandin 9-ketoreductase and type II 15-hydroxyprostaglandin dehydrogenase from swine kidney are alternate activities of a single enzyme protein. Biochem Biophys Res Commun 99(2):745\u2013751. https:\/\/doi.org\/10.1016\/0006-291X(81)91806-4","journal-title":"Biochem Biophys Res Commun"},{"key":"360_CR8","doi-asserted-by":"publisher","unstructured":"Chaudhary R, Cordova BA, Hong M, Klein BR, Contreras LA, Rashmil R, Goshevski F, Smith JNP, Taylor DJ, Pieper AA, Markowitz S, Desai AB (2025) 15-PGDH inhibition enhances hematopoietic regeneration during aging. Stem Cells 43(10). https:\/\/doi.org\/10.1093\/stmcls\/sxaf047","DOI":"10.1093\/stmcls\/sxaf047"},{"issue":"22","key":"360_CR9","doi-asserted-by":"crossref","first-page":"16437","DOI":"10.1016\/S0021-9258(19)85439-X","volume":"268","author":"AJ Chavan","year":"1993","unstructured":"Chavan AJ, Ensor CM, Wu P, Haley BE, Tai HH (1993) Photoaffinity labeling of human placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase with [alpha-32P]2N3NAD+. Identification of a peptide in the adenine ring binding domain. J Biol Chem 268(22):16437\u201316442","journal-title":"J Biol Chem"},{"issue":"6","key":"360_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1054\/plef.2002.0457","volume":"67","author":"H Cho","year":"2002","unstructured":"Cho H, Tai H-H (2002a) Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents. Prostaglandins Leukot Essent Fat Acids 67(6):461\u2013465. https:\/\/doi.org\/10.1054\/plef.2002.0457","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"2","key":"360_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0003-9861(02)00352-1","volume":"405","author":"H Cho","year":"2002","unstructured":"Cho H, Tai H-H (2002b) Thiazolidinediones as a novel class of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors. Arch Biochem Biophys 405(2):247\u2013251. https:\/\/doi.org\/10.1016\/S0003-9861(02)00352-1","journal-title":"Arch Biochem Biophys"},{"issue":"19","key":"360_CR12","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.1016\/j.bmc.2006.06.030","volume":"14","author":"H Cho","year":"2006","unstructured":"Cho H, Huang L, Hamza A, Gao D, Zhan C-G, Tai H-H (2006) Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2. Bioorg Med Chem 14(19):6486\u20136491. https:\/\/doi.org\/10.1016\/j.bmc.2006.06.030","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"360_CR13","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.4049\/jimmunol.1201272","volume":"189","author":"J Cl\u00e0ria","year":"2012","unstructured":"Cl\u00e0ria J, Dalli J, Yacoubian S, Gao F, Serhan CN (2012) Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol 189(5):2597\u20132605. https:\/\/doi.org\/10.4049\/jimmunol.1201272","journal-title":"J Immunol"},{"key":"360_CR14","doi-asserted-by":"publisher","unstructured":"Clish CB, Levy BD, Chiang N, Tai H-H, Serhan CN (2000) Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-oxoprostaglandin 13-reductase\/leukotriene B4 12-hydroxydehydrogenase in inflammation. J Biol Chem 275(33). https:\/\/doi.org\/10.1074\/jbc.M002863200","DOI":"10.1074\/jbc.M002863200"},{"issue":"4","key":"360_CR15","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1006\/bbrc.2001.5841","volume":"288","author":"CB Clish","year":"2001","unstructured":"Clish CB, Sun Y-P, Serhan CN (2001) Identification of dual cyclooxygenase\u2013eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase\/LTB4 dehydrogenase. Biochem Biophys Res Commun 288(4):868\u2013874. https:\/\/doi.org\/10.1006\/bbrc.2001.5841","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"360_CR16","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/0090-6980(77)90131-9","volume":"13","author":"AF Cockerill","year":"1977","unstructured":"Cockerill AF, Mallen DNB, Osborne DJ, Boot JR, Dawson W (1977) The identification of two novel prostaglandins and a thromboxane. Prostaglandins 13(6):1033\u20131042. https:\/\/doi.org\/10.1016\/0090-6980(77)90131-9","journal-title":"Prostaglandins"},{"issue":"6","key":"360_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3324\/haematol.2017.178376","volume":"103","author":"A Desai","year":"2018","unstructured":"Desai A, Zhang Y, Park Y, Dawson DM, Larusch GA, Kasturi L, Wald D, Ready JM, Gerson SL, Markowitz SD (2018) A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support. Haematologica 103(6):1054\u20131064. https:\/\/doi.org\/10.3324\/haematol.2017.178376","journal-title":"Haematologica"},{"key":"360_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.smim.2018.09.002","volume":"40","author":"R Doyle","year":"2018","unstructured":"Doyle R, Sadlier DM, Godson C (2018) Pro-resolving lipid mediators: agents of anti-ageing? Semin Immunol 40:36\u201348. https:\/\/doi.org\/10.1016\/j.smim.2018.09.002","journal-title":"Semin Immunol"},{"issue":"2","key":"360_CR19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S0006-291X(05)80262-1","volume":"176","author":"CM Ensor","year":"1991","unstructured":"Ensor CM, Tai H-H (1991) Site-directed mutagenesis of the conserved tyrosine 151 of human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase yields a catalytically inactive enzyme. Biochem Biophys Res Commun 176(2):840\u2013845. https:\/\/doi.org\/10.1016\/S0006-291X(05)80262-1","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"360_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0167-4838(94)90172-4","volume":"1208","author":"CM Ensor","year":"1994","unstructured":"Ensor CM, Tai H-H (1994) Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase. Biochim Biophys Acta Protein Struct Mol Enzymol 1208(1):151\u2013156. https:\/\/doi.org\/10.1016\/0167-4838(94)90172-4","journal-title":"Biochim Biophys Acta Protein Struct Mol Enzymol"},{"issue":"2\u20133","key":"360_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0929-7855(95)00040-W","volume":"12","author":"CM Ensor","year":"1995","unstructured":"Ensor CM, Tai H-H (1995) 15-Hydroxyprostaglandin dehydrogenase. J Lipid Mediat Cell Signal 12(2\u20133):313\u2013319. https:\/\/doi.org\/10.1016\/0929-7855(95)00040-W","journal-title":"J Lipid Mediat Cell Signal"},{"issue":"2","key":"360_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1006\/bbrc.1996.0405","volume":"220","author":"CM Ensor","year":"1996","unstructured":"Ensor CM, Tai H-H (1996) Site-directed mutagenesis of the conserved serine 138 of human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase to an alanine results in an inactive enzyme. Biochem Biophys Res Commun 220(2):330\u2013333. https:\/\/doi.org\/10.1006\/bbrc.1996.0405","journal-title":"Biochem Biophys Res Commun"},{"issue":"25","key":"360_CR23","doi-asserted-by":"crossref","first-page":"14888","DOI":"10.1016\/S0021-9258(18)77199-8","volume":"265","author":"CM Ensor","year":"1990","unstructured":"Ensor CM, Yang JY, Okita RT, Tai HH (1990) Cloning and sequence analysis of the cDNA for human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. J Biol Chem 265(25):14888\u201314891","journal-title":"J Biol Chem"},{"issue":"1","key":"360_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1042\/bj3300103","volume":"330","author":"CM Ensor","year":"1998","unstructured":"Ensor CM, Zhang H, Tai H-H (1998) Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung. Biochem J 330(1):103\u2013108. https:\/\/doi.org\/10.1042\/bj3300103","journal-title":"Biochem J"},{"issue":"1","key":"360_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00395-012-0319-8","volume":"108","author":"T Fr\u00f6mel","year":"2013","unstructured":"Fr\u00f6mel T, Kohlstedt K, Popp R, Yin X, Awwad K, Barbosa-Sicard E, Thomas AC, Lieberz R, Mayr M, Fleming I (2013) Cytochrome P4502S1: a novel monocyte\/macrophage fatty acid epoxygenase in human atherosclerotic plaques. Basic Res Cardiol 108(1):319. https:\/\/doi.org\/10.1007\/s00395-012-0319-8","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"360_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF00921010","volume":"2","author":"IM Goldstein","year":"1977","unstructured":"Goldstein IM, Malmsten CL, Samuelsson B, Weissmann G (1977) Prostaglandins, thromboxanes, and polymorphonuclear leukocytes. Inflammation 2(4):309\u2013317. https:\/\/doi.org\/10.1007\/BF00921010","journal-title":"Inflammation"},{"issue":"10","key":"360_CR27","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1073\/pnas.71.10.3824","volume":"71","author":"M Hamberg","year":"1974","unstructured":"Hamberg M, Svensson J, Samuelsson B (1974) Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proc Natl Acad Sci 71(10):3824\u20133828. https:\/\/doi.org\/10.1073\/pnas.71.10.3824","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"360_CR28","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","volume":"72","author":"M Hamberg","year":"1975","unstructured":"Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci 72(8):2994\u20132998. https:\/\/doi.org\/10.1073\/pnas.72.8.2994","journal-title":"Proc Natl Acad Sci"},{"issue":"14","key":"360_CR29","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1016\/j.bmc.2005.04.053","volume":"13","author":"A Hamza","year":"2005","unstructured":"Hamza A, Cho H, Tai H-H, Zhan C-G (2005) Understanding human 15-hydroxyprostaglandin dehydrogenase binding with NAD+ and PGE2 by homology modeling, docking and molecular dynamics simulation. Bioorg Med Chem 13(14):4544\u20134551. https:\/\/doi.org\/10.1016\/j.bmc.2005.04.053","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"360_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0090-6980(74)90072-0","volume":"8","author":"HS Hansen","year":"1974","unstructured":"Hansen HS (1974) Inhibition by indomethacin and aspirin of 15-hydroxy-prostaglandin dehydrogenase. Prostaglandins 8(2):95\u2013105. https:\/\/doi.org\/10.1016\/0090-6980(74)90072-0","journal-title":"Prostaglandins"},{"key":"360_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbi.2015.01.001","volume":"47","author":"JL Harrison","year":"2015","unstructured":"Harrison JL, Rowe RK, Ellis TW, Yee NS, O\u2019Hara BF, Adelson PD, Lifshitz J (2015) Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. Brain Behav Immun 47:131\u2013140. https:\/\/doi.org\/10.1016\/j.bbi.2015.01.001","journal-title":"Brain Behav Immun"},{"issue":"28","key":"360_CR32","doi-asserted-by":"crossref","first-page":"15059","DOI":"10.1016\/S0021-9258(18)95702-9","volume":"260","author":"M Haurand","year":"1985","unstructured":"Haurand M, Ullrich V (1985) Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme. J Biol Chem 260(28):15059\u201315067","journal-title":"J Biol Chem"},{"issue":"1","key":"360_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1432-1033.1993.tb17897.x","volume":"214","author":"W H\u00f6hl","year":"1993","unstructured":"H\u00f6hl W, Stahl B, Mundkowski R, Hofmann U, Meese CO, Kuhlmann U, Schlegel W (1993) Mass determination of 15-hydroxyprostaglandin dehydrogenase from human placenta and kinetic studies with (5 Z , 8 E , 10 E , 12 S )-12-hydroxy-5,8,10-heptadecatrienoic acid as substrate. Eur J Biochem 214(1):67\u201373. https:\/\/doi.org\/10.1111\/j.1432-1033.1993.tb17897.x","journal-title":"Eur J Biochem"},{"issue":"21","key":"360_CR34","doi-asserted-by":"publisher","first-page":"22615","DOI":"10.1074\/jbc.M312655200","volume":"279","author":"T Hori","year":"2004","unstructured":"Hori T, Yokomizo T, Ago H, Sugahara M, Ueno G, Yamamoto M, Kumasaka T, Shimizu T, Miyano M (2004) Structural basis of leukotriene B4 12-hydroxydehydrogenase\/15-oxo-prostaglandin 13-reductase catalytic mechanism and a possible Src homology 3 domain binding loop. J Biol Chem 279(21):22615\u201322623. https:\/\/doi.org\/10.1074\/jbc.M312655200","journal-title":"J Biol Chem"},{"issue":"1","key":"360_CR35","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41467-023-36463-7","volume":"14","author":"W Huang","year":"2023","unstructured":"Huang W, Li H, Kiselar J, Fink SP, Regmi S, Day A, Yuan Y, Chance M, Ready JM, Markowitz SD, Taylor DJ (2023) Small molecule inhibitors of 15-PGDH exploit a physiologic induced-fit closing system. Nat Commun 14(1):784. https:\/\/doi.org\/10.1038\/s41467-023-36463-7","journal-title":"Nat Commun"},{"issue":"2","key":"360_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1034\/j.1600-0404.2003.00102.x","volume":"108","author":"J I\u0142zecka","year":"2003","unstructured":"I\u0142zecka J (2003) Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients. Acta Neurol Scand 108(2):125\u2013129. https:\/\/doi.org\/10.1034\/j.1600-0404.2003.00102.x","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"360_CR37","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1096\/fj.15-279653","volume":"30","author":"Y Ishii","year":"2016","unstructured":"Ishii Y, Saeki K, Liu M, Sasaki F, Koga T, Kitajima K, Meno C, Okuno T, Yokomizo T (2016) Leukotriene B 4 receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins. FASEB J 30(2):933\u2013947. https:\/\/doi.org\/10.1096\/fj.15-279653","journal-title":"FASEB J"},{"issue":"1","key":"360_CR38","doi-asserted-by":"publisher","first-page":"13267","DOI":"10.1038\/s41598-017-13122-8","volume":"7","author":"S Iwamoto","year":"2017","unstructured":"Iwamoto S, Koga T, Ohba M, Okuno T, Koike M, Murakami A, Matsuda A, Yokomizo T (2017) Non-steroidal anti-inflammatory drug delays corneal wound healing by reducing production of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B4 receptor 2. Sci Rep 7(1):13267. https:\/\/doi.org\/10.1038\/s41598-017-13122-8","journal-title":"Sci Rep"},{"issue":"9","key":"360_CR39","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.bbadis.2015.07.005","volume":"1852","author":"G-J Kang","year":"2015","unstructured":"Kang G-J, Lee H-J, Kang YP, Kim EJ, Kim HJ, Byun HJ, Park MK, Cho H, Kwon SW, Lee C-H (2015) High-mobility group box 1 suppresses resolvin D1-induced phagocytosis via induction of resolvin D1-inactivating enzyme, 15-hydroxyprostaglandin dehydrogenase. Biochim Biophys Acta (BBA) - Mol Basis Dis 1852(9):1981\u20131988. https:\/\/doi.org\/10.1016\/j.bbadis.2015.07.005","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"2","key":"360_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1471-4159.2005.03024.x","volume":"93","author":"M Kiaei","year":"2005","unstructured":"Kiaei M, Kipiani K, Petri S, Choi D-K, Chen J, Calingasan NY, Beal MF (2005) Integrative role of cPLA with COX-2 and the effect of non-steroidal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 93(2):403\u2013411. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03024.x","journal-title":"J Neurochem"},{"key":"360_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2026.104285","volume":"95","author":"Y-K Kim","year":"2026","unstructured":"Kim Y-K, Cha YJ, Park SE, Kim HK, Kwon C, Kim G, Oh YR, V\u00e1zquez-Rosa E, Dahiya U, Moinova H, Koh Y, Gao F, Tripathi SJ, Chakraborty S, Jo D-G, Woo M, Park H, Myung S-J, Cheon J, Lee Y, Qi X, Paul BD, Fink S, Kasturi L, Lutterbaugh J, Markowitz SD, Pieper AA, Kang YP, Shin M-K (2026) Inhibiting 15-PGDH restores redox homeostasis and confers neuroprotection in Parkinson\u2019s disease. Redox Biol 95:104285. https:\/\/doi.org\/10.1016\/j.redox.2026.104285","journal-title":"Redox Biol"},{"key":"360_CR42","doi-asserted-by":"publisher","unstructured":"Koh Y, V\u00e1zquez-Rosa E, Gao F, Li H, Chakraborty S, Tripathi SJ, Barker S, Bud Z, Bangalore A, Kandjoze UP, Le\u00f3n-Alvarado RA, Sridharan PS, Cordova BA, Yu Y, Hyung J, Fang H, Singh S, Katabathula R, LaFramboise T, Kasturi L, Lutterbaugh J, Beard L, Cordova E, Cintr\u00f3n-P\u00e9rez CJ, Franke K, Fragoso MF, Miller E, Indrakumar V, Noel KL, Dhar M, Ajroud K, Zamudio C, Lopes FBTP, Bambakidis E, Zhu X, Wilson B, Flanagan ME, Gefen T, Fujioka H, Fink SP, Desai AB, Dawson D, Williams NS, Kim Y-K, Ready JM, Paul BD, Shin M-K, Markowitz SD, Pieper AA (2025) Inhibiting 15-PGDH blocks blood\u2013brain barrier deterioration and protects mice from Alzheimer\u2019s disease and traumatic brain injury. Proc Natl Acad Sci 122(21). https:\/\/doi.org\/10.1073\/pnas.2417224122","DOI":"10.1073\/pnas.2417224122"},{"issue":"1","key":"360_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0005-2744(80)90161-8","volume":"614","author":"DT-Y Kung-Chao","year":"1980","unstructured":"Kung-Chao DT-Y, Tai H-H (1980) NAD+-dependent 15-hydroxyprostaglandin dehydrogenase from porcine kidney. Biochim Biophys Acta Enzymol 614(1):1\u201313. https:\/\/doi.org\/10.1016\/0005-2744(80)90161-8","journal-title":"Biochim Biophys Acta Enzymol"},{"issue":"2","key":"360_CR44","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0021-9258(19)41931-5","volume":"250","author":"SC Lee","year":"1975","unstructured":"Lee SC, Levine L (1975) Prostaglandin metabolism. II. Identification of two 15-hydroxyprostaglandin dehydrogenase types. J Biol Chem 250(2):548\u2013552","journal-title":"J Biol Chem"},{"issue":"1","key":"360_CR45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/0006-291X(85)91432-9","volume":"129","author":"Y Liu","year":"1985","unstructured":"Liu Y, Yoden K, Shen R-F, Tai H-H (1985) 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT) is an excellent substrate for NAD+-dependent 15-hydroxyprostaglandin dehydrogenase. Biochem Biophys Res Commun 129(1):268\u2013274. https:\/\/doi.org\/10.1016\/0006-291X(85)91432-9","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"360_CR46","first-page":"60","volume":"1","author":"G Liu","year":"2012","unstructured":"Liu G, Fiala M, Mizwicki MT, Sayre J, Magpantay L, Siani A, Mahanian M, Chattopadhyay M, La Cava A, Wiedau-Pazos M (2012) Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1. Am J Neurodegener Dis 1(1):60\u201374","journal-title":"Am J Neurodegener Dis"},{"issue":"6","key":"360_CR47","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1084\/jem.20132063","volume":"211","author":"M Liu","year":"2014","unstructured":"Liu M, Saeki K, Matsunobu T, Okuno T, Koga T, Sugimoto Y, Yokoyama C, Nakamizo S, Kabashima K, Narumiya S, Shimizu T, Yokomizo T (2014) 12-hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor. J Exp Med 211(6):1063\u20131078. https:\/\/doi.org\/10.1084\/jem.20132063","journal-title":"J Exp Med"},{"issue":"19","key":"360_CR48","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.3390\/molecules26195903","volume":"26","author":"PL Mallipeddi","year":"2021","unstructured":"Mallipeddi PL, Zhang Y, Li H, Markowitz SD, Posner B (2021) Structural insights into novel 15-prostaglandin dehydrogenase inhibitors. Molecules 26(19):5903. https:\/\/doi.org\/10.3390\/molecules26195903","journal-title":"Molecules"},{"issue":"11","key":"360_CR49","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1194\/jlr.M037754","volume":"54","author":"T Matsunobu","year":"2013","unstructured":"Matsunobu T, Okuno T, Yokoyama C, Yokomizo T (2013) Thromboxane A synthase-independent production of 12-hydroxyheptadecatrienoic acid, a BLT2 ligand. J Lipid Res 54(11):2979\u20132987. https:\/\/doi.org\/10.1194\/jlr.M037754","journal-title":"J Lipid Res"},{"issue":"3","key":"360_CR50","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10571-016-0377-9","volume":"37","author":"H Miyagishi","year":"2017","unstructured":"Miyagishi H, Kosuge Y, Takano A, Endo M, Nango H, Yamagata-Murayama S, Hirose D, Kano R, Tanaka Y, Ishige K, Ito Y (2017) Increased expression of 15-hydroxyprostaglandin dehydrogenase in spinal astrocytes during disease progression in a model of amyotrophic lateral sclerosis. Cell Mol Neurobiol 37(3):445\u2013452. https:\/\/doi.org\/10.1007\/s10571-016-0377-9","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"360_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013719","volume":"5","author":"FH Niesen","year":"2010","unstructured":"Niesen FH, Schultz L, Jadhav A, Bhatia C, Guo K, Maloney DJ, Pilka ES, Wang M, Oppermann U, Heightman TD, Simeonov A (2010) High-affinity inhibitors of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships. PLoS One 5(11):e13719. https:\/\/doi.org\/10.1371\/journal.pone.0013719","journal-title":"PLoS One"},{"issue":"4","key":"360_CR52","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1084\/jem.20072329","volume":"205","author":"T Okuno","year":"2008","unstructured":"Okuno T, Iizuka Y, Okazaki H, Yokomizo T, Taguchi R, Shimizu T (2008) 12(S)-hydroxyheptadeca-5Z, 8E, 10E\u2013trienoic acid is a natural ligand for leukotriene B4 receptor 2. J Exp Med 205(4):759\u2013766. https:\/\/doi.org\/10.1084\/jem.20072329","journal-title":"J Exp Med"},{"key":"360_CR53","doi-asserted-by":"publisher","unstructured":"Palla AR, Ravichandran M, Wang YX, Alexandrova L, Yang AV, Kraft P, Holbrook CA, Sch\u00fcrch CM, Ho ATV, Blau HM (2021) Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength. Science 371(6528). https:\/\/doi.org\/10.1126\/science.abc8059","DOI":"10.1126\/science.abc8059"},{"key":"360_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.smim.2017.07.010","volume":"33","author":"K Saeki","year":"2017","unstructured":"Saeki K, Yokomizo T (2017) Identification, signaling, and functions of LTB 4 receptors. Semin Immunol 33:30\u201336. https:\/\/doi.org\/10.1016\/j.smim.2017.07.010","journal-title":"Semin Immunol"},{"issue":"9","key":"360_CR55","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/BF01133779","volume":"3","author":"B Samuelsson","year":"1983","unstructured":"Samuelsson B (1983a) From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotriences. Biosci Rep 3(9):791\u2013813. https:\/\/doi.org\/10.1007\/BF01133779","journal-title":"Biosci Rep"},{"issue":"4597","key":"360_CR56","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1126\/science.6301011","volume":"220","author":"B Samuelsson","year":"1983","unstructured":"Samuelsson B (1983b) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science (1979) 220(4597):568\u2013575. https:\/\/doi.org\/10.1126\/science.6301011","journal-title":"Science (1979)"},{"issue":"1","key":"360_CR57","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1146\/annurev.bi.47.070178.005025","volume":"47","author":"B Samuelsson","year":"1978","unstructured":"Samuelsson B, Goldyne M, Granstr\u00f6m E, Hamberg M, Hammarstr\u00f6m S, Malmsten C (1978) Prostaglandins and thromboxanes. Annu Rev Biochem 47(1):997\u20131029. https:\/\/doi.org\/10.1146\/annurev.bi.47.070178.005025","journal-title":"Annu Rev Biochem"},{"key":"360_CR1000","doi-asserted-by":"publisher","unstructured":"Serhan CN, Fiore S, Brezinski DA, Lynch S (1993) Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. Biochemistry 32(25):6313\u20136319. https:\/\/doi.org\/10.1021\/bi00076a002","DOI":"10.1021\/bi00076a002"},{"issue":"1","key":"360_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","volume":"25","author":"CN Serhan","year":"2007","unstructured":"Serhan CN (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25(1):101\u2013137. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141647","journal-title":"Annu Rev Immunol"},{"issue":"44","key":"360_CR59","doi-asserted-by":"publisher","first-page":"14609","DOI":"10.1021\/bi00044a041","volume":"34","author":"CN Serhan","year":"1995","unstructured":"Serhan CN, Maddox JF, Petasis NA, Akritopoulou-Zanze I, Papayianni A, Brady HR, Colgan SP, Madara JL (1995) Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34(44):14609\u201314615. https:\/\/doi.org\/10.1021\/bi00044a041","journal-title":"Biochemistry"},{"issue":"12","key":"360_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.114201","volume":"28","author":"CN Serhan","year":"2025","unstructured":"Serhan CN, Chiang N, Simard M, Nshimiyimana R, Rodriguez AR, Mun SJ, Irimia D, Spur BW (2025) Nouveau benzo-mimetics of 17R-resolvin D2 are potent resolution agonists for inflammation. iScience 28(12):114201. https:\/\/doi.org\/10.1016\/j.isci.2025.114201","journal-title":"iScience"},{"issue":"2","key":"360_CR61","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0003-9861(81)90091-6","volume":"206","author":"T Shimizu","year":"1981","unstructured":"Shimizu T, Kondo K, Hayaishi O (1981) Role of prostaglandin endoperoxides in the serum thiobarbituric acid reaction. Arch Biochem Biophys 206(2):271\u2013276. https:\/\/doi.org\/10.1016\/0003-9861(81)90091-6","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"360_CR62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"DL Simmons","year":"2004","unstructured":"Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56(3):387\u2013437. https:\/\/doi.org\/10.1124\/pr.56.3.3","journal-title":"Pharmacol Rev"},{"issue":"6789","key":"360_CR63","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1126\/science.adx6649","volume":"391","author":"M Singla","year":"2026","unstructured":"Singla M, Wang YX, Monti E, Bedi Y, Agarwal P, Su S, Ancel S, Hermsmeier M, Devisetti N, Pandey A, Bakooshli MA, Palla AR, Goodman S, Blau HM, Bhutani N (2026) Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration. Science 391(6789):1053\u20131062. https:\/\/doi.org\/10.1126\/science.adx6649","journal-title":"Science"},{"issue":"8","key":"360_CR64","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.bbmt.2020.04.010","volume":"26","author":"JNP Smith","year":"2020","unstructured":"Smith JNP, Otegbeye F, Jogasuria AP, Christo KF, Antczak MI, Ready JM, Gerson SL, Markowitz SD, Desai AB (2020a) Inhibition of 15-PGDH protects mice from immune-mediated bone marrow failure. Biol Blood Marrow Transplant 26(8):1552\u20131556. https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"360_CR65","doi-asserted-by":"publisher","first-page":"11657","DOI":"10.1038\/s41598-020-68336-0","volume":"10","author":"JNP Smith","year":"2020","unstructured":"Smith JNP, Witkin MD, Jogasuria AP, Christo KF, Raffay TM, Markowitz SD, Desai AB (2020b) Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis. Sci Rep 10(1):11657. https:\/\/doi.org\/10.1038\/s41598-020-68336-0","journal-title":"Sci Rep"},{"key":"360_CR66","doi-asserted-by":"publisher","unstructured":"Smith JNP, Dawson DM, Christo KF, Jogasuria AP, Cameron MJ, Antczak MI, Ready JM, Gerson SL, Markowitz SD, Desai AB (2021) 15-PGDH inhibition activates the splenic niche to promote hematopoietic regeneration. JCI Insight 6(6). https:\/\/doi.org\/10.1172\/jci.insight.143658","DOI":"10.1172\/jci.insight.143658"},{"issue":"16","key":"360_CR68","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1074\/jbc.R600038200","volume":"282","author":"Y Sugimoto","year":"2007","unstructured":"Sugimoto Y, Narumiya S (2007) Prostaglandin E receptors. J Biol Chem 282(16):11613\u201311617. https:\/\/doi.org\/10.1074\/jbc.R600038200","journal-title":"J Biol Chem"},{"issue":"13","key":"360_CR69","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1074\/jbc.M609212200","volume":"282","author":"Y-P Sun","year":"2007","unstructured":"Sun Y-P, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, Colgan SP, Petasis NA, Serhan CN (2007) Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 282(13):9323\u20139334. https:\/\/doi.org\/10.1074\/jbc.M609212200","journal-title":"J Biol Chem"},{"key":"360_CR70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0076-6879(82)86181-8","volume":"86","author":"H-H Tai","year":"1982","unstructured":"Tai H-H (1982) Assay of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase using (15S)-[15-3H]PGE2. Methods Enzymol 86:131\u2013135","journal-title":"Methods Enzymol"},{"issue":"2","key":"360_CR71","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0006-291X(74)90953-X","volume":"57","author":"H-H Tai","year":"1974","unstructured":"Tai H-H, Tai CL, Hollander CS (1974) Regulation of prostaglandin metabolism: inhibition of 15-hydroxyprostaglandin dehydrogenase by thyroid hormones. Biochem Biophys Res Commun 57(2):457\u2013462. https:\/\/doi.org\/10.1016\/0006-291X(74)90953-X","journal-title":"Biochem Biophys Res Commun"},{"key":"360_CR72","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0090-6980(02)00050-3","volume":"68\u201369","author":"H-H Tai","year":"2002","unstructured":"Tai H-H, Ensor CM, Tong M, Zhou H, Yan F (2002) Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat 68\u201369:483\u2013493. https:\/\/doi.org\/10.1016\/S0090-6980(02)00050-3","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"8","key":"360_CR73","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2174\/138161206776055958","volume":"12","author":"H Tai","year":"2006","unstructured":"Tai H, Cho H, Tong M, Ding Y (2006) NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr Pharm Des 12(8):955\u2013962. https:\/\/doi.org\/10.2174\/138161206776055958","journal-title":"Curr Pharm Des"},{"key":"360_CR74","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0090-6980(02)00045-X","volume":"68\u201369","author":"L-H Wang","year":"2002","unstructured":"Wang L-H, Kulmacz RJ (2002) Thromboxane synthase: structure and function of protein and gene. Prostaglandins Other Lipid Mediat 68\u201369:409\u2013422. https:\/\/doi.org\/10.1016\/S0090-6980(02)00045-X","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"360_CR75","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0006-291X(91)91980-Q","volume":"177","author":"L-H Wang","year":"1991","unstructured":"Wang L-H, Ohashi K, Wu KK (1991) Isolation of partial complementary DNA encoding human thromboxane synthase. Biochem Biophys Res Commun 177(1):286\u2013291. https:\/\/doi.org\/10.1016\/0006-291X(91)91980-Q","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"360_CR76","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0021-9258(19)85944-6","volume":"255","author":"K Watanabe","year":"1980","unstructured":"Watanabe K, Shimizu T, Iguchi S, Wakatsuka H, Hayashi M, Hayaishi O (1980) An NADP-linked prostaglandin D dehydrogenase in swine brain. J Biol Chem 255(5):1779\u20131782","journal-title":"J Biol Chem"},{"key":"360_CR77","doi-asserted-by":"publisher","unstructured":"Whittington RA, Planel E, Terrando N (2017) Impaired resolution of inflammation in Alzheimer\u2019s disease: a review. Front Immunol 8. https:\/\/doi.org\/10.3389\/fimmu.2017.01464","DOI":"10.3389\/fimmu.2017.01464"},{"issue":"4","key":"360_CR78","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/jb\/mvac105","volume":"173","author":"K Yasukawa","year":"2023","unstructured":"Yasukawa K, Okuno T, Ogawa N, Kobayashi Y, Yokomizo T (2023) Identification and characterization of bioactive metabolites of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B4 receptor 2. J Biochem 173(4):293\u2013305. https:\/\/doi.org\/10.1093\/jb\/mvac105","journal-title":"J Biochem"},{"key":"360_CR79","doi-asserted-by":"publisher","unstructured":"Yildiz O, Hunt GP, Schroth J, Dhillon G, Spargo TP, Al-Chalabi A, Koks S, Turner MR, Shaw PJ, Henson SM, Iacoangeli A, Malaspina A (2025) Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis. Brain Commun 7(1). https:\/\/doi.org\/10.1093\/braincomms\/fcae402","DOI":"10.1093\/braincomms\/fcae402"},{"issue":"6240","key":"360_CR80","doi-asserted-by":"publisher","first-page":"aaa2340","DOI":"10.1126\/science.aaa2340","volume":"348","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Desai A, Yang SY, Bae KB, Antczak MI, Fink SP, Tiwari S, Willis JE, Williams NS, Dawson DM, Wald D, Chen W-D, Wang Z, Kasturi L, Larusch GA, He L, Cominelli F, Di Martino L, Djuric Z, Milne GL, Chance M, Sanabria J, Dealwis C, Mikkola D, Naidoo J, Wei S, Tai H-H, Gerson SL, Ready JM, Posner B, Willson JKV, Markowitz SD (2015) TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348(6240):aaa2340. https:\/\/doi.org\/10.1126\/science.aaa2340","journal-title":"Science"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2026_360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:53:22Z","timestamp":1791356002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2026_360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":80,"URL":"https:\/\/doi.org\/10.1007\/82_2026_360","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"8 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This chapter is a review of previously published accounts; as such, no animal or human studies were performed.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}